Sandra F. Gomes is a PhD Candidate in Experimental and Clinical Pharmacology and Toxicology (expected early 2025) with over a decade of experience in clinical research, biomedical sciences, and academic roles. Her expertise lies in Pharmacology, Immunology, and Translational Medicine, with a strong record in managing clinical studies, leading interdisciplinary projects, and fostering stakeholder relationships. During her PhD, she has conducted impactful research on Inflammatory Bowel Disease (IBD) and Immune-Mediated Inflammatory Diseases (IMIDs) while spearheading initiatives in medical education that emphasize critical thinking and practical knowledge. Her achievements include securing competitive funding, presenting at national and international conferences, and developing educational resources for healthcare professionals. She also contributed to diverse projects in cardiac regeneration, autism spectrum disorders, antibiotic resistance policy, lung development, and cosmetic product development in collaboration with leading institutions globally. Passionate about bridging research with clinical practice, Sandra F. Gomes brings expertise in scientific communication and cross-functional collaboration to advance innovation and improve patient outcomes.